SCHEMBL9200322

SCHEMBL9200322

CCOc1ccc2c(C(CN)CC(=O)O)occ2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
ALDH2 P05091 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 2/20 0.37
CYP1A2 P05177 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203501 0.82 GABBR2 (0.39) AKR1C3AKR1C2MEN1KMT2ACYP1A2
SCHEMBL9196668 0.82 MAPT (0.44) MAPTMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL9198986 0.80 GABBR2 (0.43) KDM4EMEN1KMT2ACYP1A2TSHR
SCHEMBL9196657 0.79 GABBR2 (0.41) MEN1KMT2ACYP1A2TSHRCYP2C9
SCHEMBL9315751 0.79 GABBR2 (0.41) MEN1KMT2ACYP1A2TSHRCYP2C9
SCHEMBL9202387 0.79 GABBR2 (0.51) MEN1KMT2ACYP1A2TSHRCYP2C9
SCHEMBL9315726 0.79 AKR1C3 (0.41) AKR1C3AKR1C2ALDH2MAOAMAOB
SCHEMBL9195308 0.79 GAA (0.41) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL9200327 0.76 ALDH1A1 (0.45) AKR1C3AKR1C2MAOBKDM4EALDH1A1
SCHEMBL9594090 0.76 PIM1 (0.39) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463969-B1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR (FR) 1995-02-08 EP claimed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed